TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T32262	Calcitonin gene-related peptide receptor	B0YR3E	(2S)-6-Amino-2-[[(2R)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(4-phenylbutanoylamino)propanoyl]amino]-N-(2-phenylethyl)hexanamide	Investigative	11578671	C33H40Br2N4O4	716.5	C1=CC=C(C=C1)CCCC(=O)N[C@H](CC2=CC(=C(C(=C2)Br)O)Br)C(=O)N[C@@H](CCCCN)C(=O)NCCC3=CC=CC=C3	IC50 > 300000 nM	Non binder
T32262	Calcitonin gene-related peptide receptor	B3R5PS	(2S)-6-Amino-2-[[(2S)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(4-phenylbutanoylamino)propanoyl]amino]-N-(2-phenylethyl)hexanamide	Investigative	11513230	C33H40Br2N4O4	716.5	C1=CC=C(C=C1)CCCC(=O)N[C@@H](CC2=CC(=C(C(=C2)Br)O)Br)C(=O)N[C@@H](CCCCN)C(=O)NCCC3=CC=CC=C3	IC50 > 300000 nM	Non binder
T32262	Calcitonin gene-related peptide receptor	BX9S3V	(2R)-6-Amino-2-[[(2R)-3-(3,5-dibromo-4-hydroxyphenyl)-2-(4-phenylbutanoylamino)propanoyl]amino]-N-(2-phenylethyl)hexanamide	Investigative	11636224	C33H40Br2N4O4	716.5	C1=CC=C(C=C1)CCCC(=O)N[C@H](CC2=CC(=C(C(=C2)Br)O)Br)C(=O)N[C@H](CCCCN)C(=O)NCCC3=CC=CC=C3	IC50 > 300000 nM	Non binder
T32262	Calcitonin gene-related peptide receptor	BXLW16	N-{(S)-2-(4-Amino-3,5-dibromo-phenyl)-1-[(R)-5-amino-1-(4-phenyl-piperazine-1-carbonyl)-pentylcarbamoyl]-ethyl}-4-phenyl-butyramide	Investigative	44403915	C35H44Br2N6O3	756.6	C1CN(CCN1C2=CC=CC=C2)C(=O)[C@@H](CCCCN)NC(=O)[C@H](CC3=CC(=C(C(=C3)Br)N)Br)NC(=O)CCCC4=CC=CC=C4	IC50 > 300000 nM	Non binder
T32262	Calcitonin gene-related peptide receptor	BZ3YF0	N-{(S)-2-(4-Amino-3,5-dibromo-phenyl)-1-[(R)-5-amino-1-(piperazine-1-carbonyl)-pentylcarbamoyl]-ethyl}-4-phenyl-butyramide	Investigative	44403916	C29H40Br2N6O3	680.5	C1CN(CCN1)C(=O)[C@@H](CCCCN)NC(=O)[C@H](CC2=CC(=C(C(=C2)Br)N)Br)NC(=O)CCCC3=CC=CC=C3	IC50 > 300000 nM	Non binder